BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28068625)

  • 1. Loss of periplakin expression is associated with the tumorigenesis of colorectal carcinoma.
    Li X; Zhang G; Wang Y; Elgehama A; Sun Y; Li L; Gu Y; Guo W; Xu Q
    Biomed Pharmacother; 2017 Mar; 87():366-374. PubMed ID: 28068625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
    Li Y; Zhao Z; Xu C; Zhou Z; Zhu Z; You T
    Cancer Lett; 2014 Dec; 355(1):130-40. PubMed ID: 25218351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cadherin-12 enhances proliferation in colorectal cancer cells and increases progression by promoting EMT.
    Ma J; Zhao J; Lu J; Wang P; Feng H; Zong Y; Ou B; Zheng M; Lu A
    Tumour Biol; 2016 Jul; 37(7):9077-88. PubMed ID: 26762412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte nuclear factor 4α suppresses the aggravation of colon carcinoma.
    Yao HS; Wang J; Zhang XP; Wang LZ; Wang Y; Li XX; Jin KZ; Hu ZQ; Wang WJ
    Mol Carcinog; 2016 May; 55(5):458-72. PubMed ID: 25808746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-cell translocation gene 3 overexpression inhibits proliferation and invasion of colorectal cancer SW480 cells via Wnt/β-catenin signaling pathway.
    Mao D; Qiao L; Lu H; Feng Y
    Neoplasma; 2016; 63(5):705-16. PubMed ID: 27468874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitor of growth 4 suppresses colorectal cancer growth and invasion by inducing G1 arrest, inhibiting tumor angiogenesis and reversing epithelial-mesenchymal transition.
    Qu H; Yin H; Yan S; Tao M; Xie Y; Chen W
    Oncol Rep; 2016 May; 35(5):2927-35. PubMed ID: 26936485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogene FOXK1 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.
    Wu Y; Peng Y; Wu M; Zhang W; Zhang M; Xie R; Zhang P; Bai Y; Zhao J; Li A; Nan Q; Chen Y; Ren Y; Liu S; Wang J
    Oncotarget; 2016 Aug; 7(32):51150-51162. PubMed ID: 27223064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FMNL2 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.
    Li Y; Zhu X; Zeng Y; Wang J; Zhang X; Ding YQ; Liang L
    Mol Cancer Res; 2010 Dec; 8(12):1579-90. PubMed ID: 21071512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consumption of high-fat diet induces tumor progression and epithelial-mesenchymal transition of colorectal cancer in a mouse xenograft model.
    Tang FY; Pai MH; Chiang EP
    J Nutr Biochem; 2012 Oct; 23(10):1302-13. PubMed ID: 22221675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
    Qin Y; Tang B; Hu CJ; Xiao YF; Xie R; Yong X; Wu YY; Dong H; Yang SM
    Oncotarget; 2016 Jan; 7(1):351-61. PubMed ID: 26540342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing Snail suppresses tumor cell proliferation and invasion by reversing epithelial-to-mesenchymal transition and arresting G2/M phase in non-small cell lung cancer.
    Yang X; Han M; Han H; Wang B; Li S; Zhang Z; Zhao W
    Int J Oncol; 2017 Apr; 50(4):1251-1260. PubMed ID: 28259904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BAG3 regulates cell proliferation, migration, and invasion in human colorectal cancer.
    Shi H; Xu H; Li Z; Zhen Y; Wang B; Huo S; Xiao R; Xu Z
    Tumour Biol; 2016 Apr; 37(4):5591-7. PubMed ID: 26577854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The calcium-sensing receptor suppresses epithelial-to-mesenchymal transition and stem cell- like phenotype in the colon.
    Aggarwal A; Prinz-Wohlgenannt M; Gröschel C; Tennakoon S; Meshcheryakova A; Chang W; Brown EM; Mechtcheriakova D; Kállay E
    Mol Cancer; 2015 Mar; 14():61. PubMed ID: 25879211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of linc-POU3F3 suppresses the proliferation, apoptosis, and migration resistance of colorectal cancer.
    Shan TD; Xu JH; Yu T; Li JY; Zhao LN; Ouyang H; Luo S; Lu XJ; Huang CZ; Lan QS; Zhong W; Chen QK
    Oncotarget; 2016 Jan; 7(1):961-75. PubMed ID: 26510906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.
    Mu Y; Zou H; Chen B; Fan Y; Luo S
    Biomed Pharmacother; 2017 Jun; 90():548-554. PubMed ID: 28407575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KLF8 promotes tumorigenesis, invasion and metastasis of colorectal cancer cells by transcriptional activation of FHL2.
    Yan Q; Zhang W; Wu Y; Wu M; Zhang M; Shi X; Zhao J; Nan Q; Chen Y; Wang L; Cheng T; Li J; Bai Y; Liu S; Wang J
    Oncotarget; 2015 Sep; 6(28):25402-17. PubMed ID: 26320172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of LAPTM5 suppresses cell proliferation and viability inducing cell cycle arrest at G0/G1 phase of bladder cancer cells.
    Chen L; Wang G; Luo Y; Wang Y; Xie C; Jiang W; Xiao Y; Qian G; Wang X
    Int J Oncol; 2017 Jan; 50(1):263-271. PubMed ID: 27922670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.